Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Safety of drug use in patients with a primary mitochondrial disease: An international Delphi‐based consensus

Journal of Inherited Metabolic Disease(2020)10.1002/jimd.12196Source: DataRank Database

Safety of drug use in patients with a primary mitochondrial disease: An international Delphi‐based consensus is a research paper published in Journal of Inherited Metabolic Disease (2020). On theSindex it has a DataRank of 0. It has been cited 68 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access68 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (28 grants)Impact (FWCI 3.21)OA: hybridTopics (44)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

David A. Brown ORCID,Mitchell E. Allen,Laurence A. Bindoff ORCID,Gráinne S. Gorman ORCID,Amel Karaa ORCID

Live enrichment

PubMed:32030781 PMC:PMC7383489 OpenAlex:https://openalex.org/W3004722903

European Molecular Biology Organization

Grant: ALTF 268‐2016

Fondazione Telethon

Grant: GUP09004

Fondazione Telethon

Grant: GSP16001

Instituto de Salud Carlos III

Grant: ISCIII‐FIS PI17/00109

Medical Research Council

Grant: MR/S002065/1

Wellcome Trust

Grant: 203105/Z/16/Z

Wellcome Trust

Grant: 204709/Z/16/Z

Prinses Beatrix Spierfonds

Grant: WO.R17‐19

National Institute for Health Research

Grant: CL‐2016‐01‐003

National Institutes of Health

Grant: HL123647

Medical Research Council Canada

Grant: L016354

Medical Research Council

Grant: 13/NE/0326

Action Medical Research

Grant: 2682

NHLBI NIH HHS

Grant: R56 HL123647

National Institute for Health Research (NIHR)

Grant: CL-2016-01-003

NHLBI NIH HHS

Grant: R01 HL123647

NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research

National Institute of Food and Agriculture

Virginia Polytechnic Institute and State University

Newcastle upon Tyne Hospitals NHS Foundation Trust

Newcastle University

Action Medical Research

Muscular Dystrophy UK

Instituto de Salud Carlos III

Wellcome Trust

Biotechnology and Biological Sciences Research Council

European Commission

Biotechnology and Biological Sciences Research Council

FWCI

3.21

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jimd.12196

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jimd.12196

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjimd.12196

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jimd.12196

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/jimd.12196

Fields of Study

Mitochondrial Function and PathologyMetabolism and Genetic DisordersGenomics and Rare DiseasesHumansConsensusDelphi TechniqueDrug DesignDrug-Related Side Effects and Adverse ReactionsInternationalityMitochondriaMitochondrial DiseasesPharmaceutical PreparationsToxicity Tests

MeSH Terms

Delphi TechniquePharmaceutical PreparationsHumansMitochondriaDrug DesignPractice Guidelines as TopicToxicity TestsMitochondrial DiseasesConsensusInternationalityDrug-Related Side Effects and Adverse Reactions

Keywords

MedicineMitochondrial diseaseDrugHuman geneticsMEDLINEDelphi methodIntensive care medicineBioinformaticsPharmacologyMitochondrial DNABiologyComputer scienceGeneticsBiochemistrySafetyDrugsIn vivo studiesin vitro studiesmitochondrial diseasesMitochondrial Toxicity

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors

10.6084/m9.figshare.26607901.v1figshare

Additional file 1 of The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors

10.6084/m9.figshare.26607901figshare